Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity

Mitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, Komal Shah, Eric K. Singhi, Melvin Rivera, Luisa Solis Soto, Wei-Lien Wang, Lingzhi Hong, Ziping Li, Mehmet Altan, Maria Franco Vega, Patricia de Groot, Alexa Halliday, Joshua Jacome, Jianjun Zhang, Xiuning Le, Jenny Pozadzides, Janet Tu, Celyne Bueno Hume, George Blumenschein, Ferdinandos Skoulidis, Tina Cascone, Frank Fossella, Marcelo Vailati Negrao, Natalie Vokes, Don Gibbons, Haniel Araujo, Anne Tsao, John Victor Heymach, Lauren Averett Byers, Carl Michael Gay, Bingnan Zhang

Open source

DOI: 10.1200/po-25-00836
Published: 2026-04
Container: JCO Precision Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-25-00836,
  title = {Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity},
  author = {Mitchell Parma and Kaiwen Wang and Ceylan Altintas Taslicay and Komal Shah and Eric K. Singhi and Melvin Rivera and Luisa Solis Soto and Wei-Lien Wang and Lingzhi Hong and Ziping Li and Mehmet Altan and Maria Franco Vega and Patricia de Groot and Alexa Halliday and Joshua Jacome and Jianjun Zhang and Xiuning Le and Jenny Pozadzides and Janet Tu and Celyne Bueno Hume and George Blumenschein and Ferdinandos Skoulidis and Tina Cascone and Frank Fossella and Marcelo Vailati Negrao and Natalie Vokes and Don Gibbons and Haniel Araujo and Anne Tsao and John Victor Heymach and Lauren Averett Byers and Carl Michael Gay and Bingnan Zhang},
  year = {2026},
  journal = {JCO Precision Oncology},
  doi = {10.1200/po-25-00836},
  url = {https://doi.org/10.1200/po-25-00836}
}

RIS

TY  - JOUR
TI  - Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity
AU  - Mitchell Parma
AU  - Kaiwen Wang
AU  - Ceylan Altintas Taslicay
AU  - Komal Shah
AU  - Eric K. Singhi
AU  - Melvin Rivera
AU  - Luisa Solis Soto
AU  - Wei-Lien Wang
AU  - Lingzhi Hong
AU  - Ziping Li
AU  - Mehmet Altan
AU  - Maria Franco Vega
AU  - Patricia de Groot
AU  - Alexa Halliday
AU  - Joshua Jacome
AU  - Jianjun Zhang
AU  - Xiuning Le
AU  - Jenny Pozadzides
AU  - Janet Tu
AU  - Celyne Bueno Hume
AU  - George Blumenschein
AU  - Ferdinandos Skoulidis
AU  - Tina Cascone
AU  - Frank Fossella
AU  - Marcelo Vailati Negrao
AU  - Natalie Vokes
AU  - Don Gibbons
AU  - Haniel Araujo
AU  - Anne Tsao
AU  - John Victor Heymach
AU  - Lauren Averett Byers
AU  - Carl Michael Gay
AU  - Bingnan Zhang
PY  - 2026
JO  - JCO Precision Oncology
DO  - 10.1200/po-25-00836
UR  - https://doi.org/10.1200/po-25-00836
ER  -

APA

Parma, M., Wang, K., Taslicay, C. A., Shah, K., Singhi, E. K., Rivera, M., Soto, L. S., Wang, W., Hong, L., Li, Z., Altan, M., Vega, M. F., Groot, P. D., Halliday, A., Jacome, J., Zhang, J., Le, X., Pozadzides, J., Tu, J., Hume, C. B., Blumenschein, G., Skoulidis, F., Cascone, T., Fossella, F., Negrao, M. V., Vokes, N., Gibbons, D., Araujo, H., Tsao, A., Heymach, J. V., Byers, L. A., Gay, C. M., & Zhang, B. (2026). Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity. JCO Precision Oncology. https://doi.org/10.1200/po-25-00836

Source records

crossref · retrieved 2026-09-25T13:53:40.132Z